[1]
|
Alzheimer’s Association (2012) Alzheimer’s disease facts and figures. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 8, 131-168.
|
[2]
|
Corbett, A., Smith, J. and Ballard, C. (2012) New and emerging treatments for Alzheimer’s disease. Expert Review of Neurotherapeutics, 12, 535-543.
doi:10.1586/ern.12.43
|
[3]
|
Benilova, I., Karran, E. and De Strooper, B. (2012) The toxic Abeta oligomer and Alzheimer’s disease: An emperor in need of clothes. Nature Neuroscience, 15, 349- 57. doi:10.1038/nn.3028
|
[4]
|
Zhang, F., et al. (2012) Roles of brain-derived neurotrophic factor/tropomyosin-related kinase B (BDNF/TrkB) signalling in Alzheimer’s disease. Journal of Clinical Neuroscience, 19, 946-949.
doi:10.1016/j.jocn.2011.12.022
|
[5]
|
Minichiello, L. (2009) TrkB signalling pathways in LTP and learning. Nature Reviews Neuroscience, 10, 850-860.
doi:10.1038/nrn2738
|
[6]
|
Rothman, S.M., et al. (2012) Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health. Annals of the New York Academy of Sciences, 1264, 49-63.
doi:10.1111/j.1749-6632.2012.06525.x
|
[7]
|
Nagahara, A.H. and Tuszynski, M.H. (2011) Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nature Reviews Drug Discovery, 10, 209-219.
doi:10.1038/nrd3366
|
[8]
|
Longo, F.M., et al. (2007) Small molecule neurotrophin receptor ligands: Novel strategies for targeting Alzheimer’s disease mechanisms. Current Alzheimer Research, 4, 503-506. doi:10.2174/156720507783018316
|
[9]
|
Luberg, K., et al. (2010) Human TrkB gene: Novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development. Journal of Neurochemistry, 113, 952-964.
doi:10.1111/j.1471-4159.2010.06662.x
|
[10]
|
Stoilov, P., Castren, E. and Stamm, S. (2002) Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism. Biochemical and Biophysical Research Communications, 290, 1054-1065. doi:10.1006/bbrc.2001.6301
|
[11]
|
Baxter, G.T., et al. (1997) Signal transduction mediated by the truncated trkB receptor isoforms, trkB.T1 and trkB. T2. The Journal of Neuroscience, 17, 2683-2690.
|
[12]
|
Wong, J., et al. (2012) Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer’s disease. Neuroscience, 210, 363-374. doi:10.1016/j.neuroscience.2012.02.037
|
[13]
|
Ginsberg, S.D., et al. (2006) Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer’s disease. Journal of Neurochemistry, 97, 475-487.
doi:10.1111/j.1471-4159.2006.03764.x
|
[14]
|
Poon, W.W., et al. (2009) β-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiology Aging, 32, 821-833.
|
[15]
|
Tong, L., et al. (2004) Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. Journal of Neuroscience, 24, 6799-6809.
doi:10.1523/JNEUROSCI.5463-03.2004
|
[16]
|
Holback, S., Adlerz, L. and Iverfeldt, K. (2005) Increased processing of APLP2 and APP with concomitant formation of APP intracellular domains in BDNF and retinoic acid-differentiated human neuroblastoma cells. Journal of Neurochemistry, 95, 1059-1068.
doi:10.1111/j.1471-4159.2005.03440.x
|
[17]
|
Ruiz-Leon, Y. and Pascual, A. (2001) Brain-derived neurotrophic factor stimulates beta-amyloid gene promoter activity by a Ras-dependent/AP-1-independent mechanism in SH-SY5Y neuroblastoma cells. Journal of Neuroche mistry, 79, 278-285.
doi:10.1046/j.1471-4159.2001.00547.x
|
[18]
|
Ruiz-Leon, Y. and Pascual, A. (2003) Induction of tyrosine kinase receptor b by retinoic acid allows brain-derived neurotrophic factor-induced amyloid precursor protein gene expression in human SH-SY5Y neuroblastoma cells. Neuroscience, 120, 1019-1026.
doi:10.1016/S0306-4522(03)00391-9
|
[19]
|
Ruiz-Leon, Y. and Pascual, A. (2004) Regulation of betaamyloid precursor protein expression by brain-derived neurotrophic factor involves activation of both the Ras and phosphatidylinositide 3-kinase signalling pathways. Journal of Neurochemistry, 88, 1010-1018.
doi:10.1046/j.1471-4159.2003.02226.x
|
[20]
|
Ansaloni, S., et al. (2011) TrkB isoforms differentially affect AICD production though their intracellular functional domains. International Journal of Alzheimer’s Disease, 2011, Article ID: 729382.
|
[21]
|
Rajagopal, R., et al., (2004) Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. Journal of Neuroscience, 24, 6650-6658.
doi:10.1523/JNEUROSCI.0010-04.2004
|
[22]
|
Schecterson, L.C., et al. (2010) Trk activation in the secretory pathway promotes Golgi fragmentation. Molecular and Cellular Neuroscience, 43, 403-413.
doi:10.1016/j.mcn.2010.01.007
|
[23]
|
Groth, R.D. and Mermelstein, P.G. (2003) Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: A role for the transcription factor NFATc4 in neurotrophin-mediated gene expression. Journal of Neuroscience, 23, 8125-8134.
|
[24]
|
Xie, Z., et al. (2007) RNA interference silencing of the adaptor molecules ShcC and Fe65 differentially affect amyloid precursor protein processing and Abeta generation. The Journal of Biological Chemistry, 282, 4318- 4325. doi:10.1074/jbc.M609293200
|
[25]
|
Cho, H.J., et al. (2008) Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling. Aging Cell, 7, 137- 147. doi:10.1111/j.1474-9726.2007.00360.x
|
[26]
|
Manley, K., O’Hara, B.A. and Atwood, W.J. (2008) Nuclear factor of activated T-cells (NFAT) plays a role in SV40 infection. Virology, 372, 48-55.
doi:10.1016/j.virol.2007.10.029
|
[27]
|
Kamenetz, F., et al. (2003) APP processing and synaptic function. Neuron, 37, 925-937.
doi:10.1016/S0896-6273(03)00124-7
|
[28]
|
Hoe, H.S., et al. (2009) The effects of amyloid precursor protein on postsynaptic composition and activity. The Journal of Biological Chemistry, 284, 8495-8506.
doi:10.1074/jbc.M900141200
|
[29]
|
Caille, I., et al. (2004) Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone. Development, 131, 2173-2181.
doi:10.1242/dev.01103
|
[30]
|
Obregon, D., et al. (2012) Soluble amyloid precursor protein-alpha modulates beta-secretase activity and amyloid-beta generation. Nature Communications, 3, 777.
doi:10.1038/ncomms1781
|
[31]
|
Postina, R. (2012) Activation of alpha-secretase cleavage. Journal of Neurochemistry, 120, 46-54.
doi:10.1111/j.1471-4159.2011.07459.x
|
[32]
|
Turner, S.D., et al. (2007) The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms. Cell Signal, 19, 740-747. doi:10.1016/j.cellsig.2006.09.007
|
[33]
|
Gomes, J.R., et al. (2012) Excitotoxicity downregulates TrkB.FL signaling and upregulates the neuroprotective truncated TrkB receptors in cultured hippocampal and striatal neurons. Journal of Neuroscience, 32, 4610-4622.
doi:10.1523/JNEUROSCI.0374-12.2012
|
[34]
|
Abdul, H.M., et al. (2009) Cognitive decline in Alzheimer’s disease is associated with selective changes in calcineurin/NFAT signaling. Journal of Neuroscience, 29, 12957-12969. doi:10.1523/JNEUROSCI.1064-09.2009
|
[35]
|
Holler, C.J., et al. (2012) BACE2 expression increases in human neurodegenerative disease. The American Journal of Pathology, 180, 337-350.
doi:10.1016/j.ajpath.2011.09.034
|